These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37474429)
21. Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy. Xue Y; Yan X; Li D; Dong S; Ping Y Nat Commun; 2024 Mar; 15(1):2270. PubMed ID: 38491004 [TBL] [Abstract][Full Text] [Related]
22. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development. Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247 [TBL] [Abstract][Full Text] [Related]
23. Reprogramming Tumor-Associated Macrophages with a Se-Based Core-Satellite Nanoassembly to Enhance Cancer Immunotherapy. Zhang X; Li G; Yin J; Pan W; Li Y; Li N; Tang B Nano Lett; 2024 Jul; 24(29):9104-9114. PubMed ID: 39007505 [TBL] [Abstract][Full Text] [Related]
24. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model. Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462 [TBL] [Abstract][Full Text] [Related]
25. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth. Ramesh A; Malik V; Brouillard A; Kulkarni A J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955 [TBL] [Abstract][Full Text] [Related]
26. Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment. Wang J; Deng S; Cheng D; Gu J; Qin L; Mao F; Xue Y; Jiang Z; Chen M; Zou F; Huang N; Cao Y; Cai K J Transl Med; 2024 Oct; 22(1):908. PubMed ID: 39375706 [TBL] [Abstract][Full Text] [Related]
28. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422 [TBL] [Abstract][Full Text] [Related]
29. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy. Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762 [TBL] [Abstract][Full Text] [Related]
30. Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration. Chen XY; Yan MY; Liu Q; Yu BX; Cen Y; Li SY ACS Nano; 2023 Aug; 17(16):16056-16068. PubMed ID: 37578051 [TBL] [Abstract][Full Text] [Related]
31. [Anti-CD206 antibody-conjugated Fe Fu Q; Tang H; Zhang P; Que K; Liu Z; Zhou Y Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):246-254. PubMed ID: 32376536 [TBL] [Abstract][Full Text] [Related]
32. Functional 2D Iron-Based Nanosheets for Synergistic Immunotherapy, Phototherapy, and Chemotherapy of Tumor. Wang X; Cheng Y; Han X; Yan J; Wu Y; Song P; Wang Y; Li X; Zhang H Adv Healthc Mater; 2022 Oct; 11(19):e2200776. PubMed ID: 35912918 [TBL] [Abstract][Full Text] [Related]
33. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages. Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523 [TBL] [Abstract][Full Text] [Related]
34. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects. Xiao H; Guo Y; Li B; Li X; Wang Y; Han S; Cheng D; Shuai X ACS Cent Sci; 2020 Jul; 6(7):1208-1222. PubMed ID: 32724855 [TBL] [Abstract][Full Text] [Related]
35. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy. Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949 [TBL] [Abstract][Full Text] [Related]
36. NIR-Actuated Targeted Janus Nanomotors Remodel Immunosuppressive Tumor Microenvironment for Augmented Cancer Immunotherapy. Zhou X; Ma E; Zhang Y; Xing Y; Xu W; Chen L; Zhou H; Zhang X; Jiang C; Xu K; Wang H; Zheng S Adv Healthc Mater; 2024 Jan; 13(2):e2302272. PubMed ID: 37824087 [TBL] [Abstract][Full Text] [Related]
37. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy. Chen M; Shen Y; Pu Y; Zhou B; Bing J; Ge M; Zhu Y; Gao S; Wu W; Zhou M; Shi J Biomaterials; 2023 Dec; 303():122386. PubMed ID: 37977008 [TBL] [Abstract][Full Text] [Related]
38. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800 [TBL] [Abstract][Full Text] [Related]
39. Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor-Associated Macrophages to Potentiate Cancer Immunotherapy. Zhang CJ; Li JM; Xu D; Wang DD; Qi MH; Chen F; Wu B; Deng K; Huang SW Adv Sci (Weinh); 2024 Oct; 11(38):e2403044. PubMed ID: 39119940 [TBL] [Abstract][Full Text] [Related]
40. Cationic polysaccharide spermine-pullulan drives tumor associated macrophage towards M1 phenotype to inhibit tumor progression. Xie L; Yang Y; Meng J; Wen T; Liu J; Xu H Int J Biol Macromol; 2019 Feb; 123():1012-1019. PubMed ID: 30439425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]